Skip to content

Drug interactions

Docetaxel + Tipranavir

Severity: Major

Docetaxel and Tipranavir: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tipranavir, co-administered with ritonavir, inhibits CYP3A4 and may substantially raise docetaxel levels. This can intensify neutropenia, mucositis and other toxicities.

What this interaction means in plain words

Docetaxel and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Docetaxel belongs to Oncology; Tipranavir belongs to Anti Virals.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated docetaxel metabolism (with ritonavir) reduces clearance.

What to do

Avoid if possible; otherwise reduce docetaxel dose and monitor blood counts and toxicity closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Docetaxel and Tipranavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Docetaxel with Tipranavir?

MediHelp rates the interaction as major. Docetaxel and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tipranavir, co-administered with ritonavir, inhibits CYP3A4 and may substantially raise docetaxel levels. This can intensify neutropenia, mucositis and other toxicities.

How serious is the interaction between Docetaxel and Tipranavir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; otherwise reduce docetaxel dose and monitor blood counts and toxicity closely.

What other medicines interact with Docetaxel?

MediHelp also lists interactions of Docetaxel with, for example, Adenovirus types 4 and 7 live, Atazanavir, Belatacept. The full list is on the Docetaxel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in